DORA, the Narrative CV, and Altmetrics
How to Evaluate Researchers Without the Impact Factor
A practical guide for university PR offices, department heads, promotion committees, and the researchers who need to navigate what is actually changing.
Honest analysis, practical guides, and strategic thinking from the people who work at the intersection of science and the market every day.
How to Evaluate Researchers Without the Impact Factor
A practical guide for university PR offices, department heads, promotion committees, and the researchers who need to navigate what is actually changing.
How to Publish for Free and Achieve Maximum Visibility
The Three Publications That Secured €1.2 Million in Grant Funding
Why Investors Trust Peer-Reviewed Evidence More Than "We Calculated It Ourselves"
What Investors Are Actually Looking for in Your Papers in 2026
How a European University Research Group Achieved +340% Reach
5 Techniques to Make Your Paper Read by More Than 12 Colleagues
How to Turn a Scientific Publication Into a Viral LinkedIn Case Study for Investors
Why Everyone Is Publishing Only "Data-Rich" Topics — and How to Break Into Niche Fields
How to Use AI in Scientific Publications Without Losing Authorship
Will a Machine Judge Your Papers by 2027?
Publishing Faster Without Losing Credibility
How Not to Fall Into the "AI-Generated" Trap in 2026
How to Make a Physics Paper Noticed Without a 10+ Impact Factor
How Publish or Perish Is Compromising the Quality of Materials and Catalysis Research
How Publishing on bioRxiv Can Accelerate Investment in Your Biotech Venture
Why Even Nature Rejects 92% of Submissions — and What Young Laboratories Can Do About It
How to Write Biotech Papers Without the Risk of Retraction
What It Really Costs to Publish a Medtech Breakthrough in 2025
Why 2025 Became the Year the Scientific Literature Started Eating Itself
The Burnout Cost of Asking Scientists to Be Their Own Marketing Departments
Why the Journey From Laboratory to Spinout Remains Unnecessarily Brutal
Why Researchers Keep Solving Problems That Have Already Been Solved
Why the Scientist Who Can Close a Deal Changes Everything
A Series on Science, Commercialisation, and the Infrastructure That Is Missing
Why the Right Network Is Everything — and Why Most Researchers Have the Wrong One
Why Applied Science Still Sits Below Pure Research in Academic Culture
On the Distance Between What Science Can Do and What It Actually Does
Why Scientists Walk Into the Most Important Room of Their Career Completely Unprepared
Why Researchers Either Skip Market Proof Entirely or Pay Far Too Much For It
The Quiet Grief of the Researcher Who Wants to See Their Work in the World
The Mentorship Gap That Leaves Researcher-Founders Navigating Alone
Why Fear of Dilution Is Keeping Scientists From the Table
Why Universities Still Don't Know How to Celebrate a Spinout
Why Clinical Trials and Approval Pathways Stop More Good Science Than Bad
Why the Boldest Scientific Ideas Are the Hardest to Fund
Why Investment Doesn't Always Follow the Best Science
The Identity Crisis Keeping Research Out of the Room
Why Scientists Can't Pitch — and Why That Is Everyone's Problem
When Scientific Excellence and Commercial Reality Speak Different Languages
Why Universities Consistently Fail to Monetise the Knowledge They Create
How Academic Publishing Turned Knowledge into a Toll Road
Why Universities Still Don't Know How to Value a Breakthrough
How Science Became a Reporting Exercise
Inside the Technology Transfer Bottleneck
Why Brilliant Research Keeps Disappearing Between the Lab and the World
Thirty minutes, no pitch. We will tell you plainly whether we are the right people for it.
We answer within one business day
Ask Abscilem
Hello. What can I help you with?
Questions here are kept for 30 days and read by our team. Please keep unpublished results out of it.How we handle data